Despite research on a male contraceptive pill beginning around the same time as its female counterpart, no product ever made it to market. But that could soon change, with a new non-hormonal male pill entering human trials in the UK late last year. Ian Sample talks to bioethicist Prof Lisa Campo-Engelstein from the University of Texas and Prof Chris Barratt from the University of Dundee about why male contraceptives have been so difficult to develop, and what kind of options are in the pipeline.
How to listen to podcasts: everything you need to know
